New Delhi (thestates.news) | The 9th edition of PharmaMed 2026, organized by PHD Chamber of Commerce & Industry (PHDCCI) in collaboration with the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, commenced on a high note today in New Delhi. Centered around the theme “Healthcare Equity: Reaching Every Citizen of Viksit Bharat,” the inaugural session brought together Senior policymakers, global regulators, eminent industry leaders, and experts setting the stage for meaningful dialogue on strengthening India’s pharmaceutical sector.
Highlighting public health priorities, Dr. Vinod K. Paul, Member, NITI Aayog, noted the sector’s critical role in healthcare affordability. He said “Medicines account for a significant share of out-of-pocket healthcare expenses, making the pharmaceutical industry central to equity and financial protection,”
Emphasising the role of Research, Development, and Innovation (RDI) Dr. Paul said “India has the talent, scale, and scientific capability. If they are aligned with strong RDI, India will not just participate in global pharma, but will lead it. The Ayushman Bharat initiative is transforming 1,80,000 health centres, providing 105–172 essential medicines free at primary levels, a powerful step toward universal health coverage” he added. (s-pib)
